ARDX
Price
$3.68
Change
+$0.04 (+1.10%)
Updated
Jun 6 closing price
Capitalization
868.5M
53 days until earnings call
CSCI
Price
$3.61
Change
-$0.11 (-2.96%)
Updated
Jun 6 closing price
Capitalization
11.47M
Interact to see
Advertisement

ARDX vs CSCI

Header iconARDX vs CSCI Comparison
Open Charts ARDX vs CSCIBanner chart's image
Ardelyx
Price$3.68
Change+$0.04 (+1.10%)
Volume$6.93M
Capitalization868.5M
COSCIENS Biopharma
Price$3.61
Change-$0.11 (-2.96%)
Volume$3.25K
Capitalization11.47M
ARDX vs CSCI Comparison Chart
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. CSCI commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Buy and CSCI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (ARDX: $3.91 vs. CSCI: $3.41)
Brand notoriety: ARDX and CSCI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 57% vs. CSCI: 12%
Market capitalization -- ARDX: $868.5M vs. CSCI: $11.47M
ARDX [@Biotechnology] is valued at $868.5M. CSCI’s [@Biotechnology] market capitalization is $11.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileCSCI’s FA Score has 0 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • CSCI’s FA Score: 0 green, 5 red.
According to our system of comparison, ARDX is a better buy in the long-term than CSCI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 5 TA indicator(s) are bullish while CSCI’s TA Score has 1 bullish TA indicator(s).

  • ARDX’s TA Score: 5 bullish, 4 bearish.
  • CSCI’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, ARDX is a better buy in the short-term than CSCI.

Price Growth

ARDX (@Biotechnology) experienced а -2.01% price change this week, while CSCI (@Biotechnology) price change was -3.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ARDX is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($868M) has a higher market cap than CSCI($11.5M). CSCI YTD gains are higher at: 23.134 vs. ARDX (-22.880). CSCI has higher annual earnings (EBITDA): -9.89M vs. ARDX (-16.71M). ARDX has more cash in the bank: 250M vs. CSCI (20M). CSCI has less debt than ARDX: CSCI (1.62M) vs ARDX (153M). ARDX has higher revenues than CSCI: ARDX (334M) vs CSCI (7.6M).
ARDXCSCIARDX / CSCI
Capitalization868M11.5M7,548%
EBITDA-16.71M-9.89M169%
Gain YTD-22.88023.134-99%
P/E RatioN/AN/A-
Revenue334M7.6M4,396%
Total Cash250M20M1,250%
Total Debt153M1.62M9,468%
FUNDAMENTALS RATINGS
ARDX vs CSCI: Fundamental Ratings
ARDX
CSCI
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
52
Fair valued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
9597
PRICE GROWTH RATING
1..100
9056
P/E GROWTH RATING
1..100
4696
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CSCI's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for ARDX (98). This means that CSCI’s stock grew somewhat faster than ARDX’s over the last 12 months.

CSCI's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as ARDX (100). This means that CSCI’s stock grew similarly to ARDX’s over the last 12 months.

ARDX's SMR Rating (95) in the Biotechnology industry is in the same range as CSCI (97). This means that ARDX’s stock grew similarly to CSCI’s over the last 12 months.

CSCI's Price Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for ARDX (90). This means that CSCI’s stock grew somewhat faster than ARDX’s over the last 12 months.

ARDX's P/E Growth Rating (46) in the Biotechnology industry is somewhat better than the same rating for CSCI (96). This means that ARDX’s stock grew somewhat faster than CSCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARDXCSCI
RSI
ODDS (%)
Bullish Trend 11 days ago
81%
Bearish Trend 23 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
76%
Bearish Trend 23 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 23 days ago
89%
MACD
ODDS (%)
Bullish Trend 11 days ago
85%
Bearish Trend 23 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
79%
Bullish Trend 23 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
82%
Bullish Trend 23 days ago
76%
Advances
ODDS (%)
Bullish Trend 19 days ago
86%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
81%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
89%
Bearish Trend 23 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 23 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with HRTX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-1.51%
HRTX - ARDX
37%
Loosely correlated
-3.17%
RIGL - ARDX
37%
Loosely correlated
-2.19%
CSCI - ARDX
35%
Loosely correlated
+2.12%
PCVX - ARDX
34%
Loosely correlated
-1.10%
RNAC - ARDX
34%
Loosely correlated
+3.65%
More

CSCI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CSCI has been closely correlated with NCNA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CSCI jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
+2.12%
NCNA - CSCI
88%
Closely correlated
-3.85%
RNAC - CSCI
88%
Closely correlated
+3.65%
WINT - CSCI
87%
Closely correlated
+5.12%
BCDA - CSCI
81%
Closely correlated
+1.93%
NRXP - CSCI
79%
Closely correlated
+0.39%
More